Glyburide Tablet
Product Images NDC 51655-659

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 51655-659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 659 52 Master Bottle Label Approval Rev A 03 21)

Label for GlyBURIDE Tablets USP 2.5 mg oral dosage form from Northwind Health Company, LLC. The package contains 30 tablets, Rx only. The label includes storage instructions, manufacturer data, and a barcode. It states each tablet contains 2.5 mg glyburide and includes lot and expiration placeholders.*

FDA Label Image

Image (Dde70749 E2c1 4ba6 Bdba F08a456e803c 01)

Chemical structure of glyburide, as illustrated by a molecular diagram showing its aromatic rings, sulfonylurea group, and other functional groups.*

FDA Label Image

Logo (Dde70749 E2c1 4ba6 Bdba F08a456e803c 02)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.